-
Post date
July 4, 2021
-
Posted by
Lukas Kane
-
Posted in
Biotech, Breakthrough Therapy, Bucillamine, CBD research and development, clinical testing, Fast Track, FDA approval, Featured Content, Health Science, ischemia-reperfusion injury, Kane, Mushroom Moves, Mushrooms, Orphan Drug, preclinical testing, preclinical trials, psilcoybin, Psychedelics, Rare Pediatric Disease, research and development, Revive Therapeutics, RVV.C, Scribes, Series, UCSF, University of California
-
Post date
June 16, 2021
-
Posted by
Piers Eaton
-
Posted in
CYB004, cybin, CYBN.NE, GAD, Generalized Anxiety Disorder, Health Science, mental health, Mushroom Moves, Mushrooms, psilocybin, Psychedelics, SAD, Series, shrooms, Social Anxiety Disorder
-
Post date
June 14, 2021
-
Posted by
Piers Eaton
-
Posted in
COOL.C, Core One Labs, Eaton, Mushroom Moves, Mushrooms, Patent Application, Psychedelics, Scribes, Series, Vocan, Vocan Brazil
